The effect of disulfide bond reduction on the properties of cholinergic receptors in chick muscle.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002217:Carbachol / Q000037:antagonists & inhibitors; D002645:Chickens; D004220:Disulfides; D004229:Dithiothreitol / Q000494:pharmacology*; D004347:Drug Interactions; D004491:Edrophonium / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D066298:In Vitro Techniques; D009132:Muscles / Q000187:drug effects*; D009150:Mustard Compounds / Q000494:pharmacology; D009284:Naphthols / Q000494:pharmacology; D009388:Neostigmine / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology; D009578:Nitrobenzenes / Q000494:pharmacology; D010084:Oxidation-Reduction; D011188:Potassium / Q000494:pharmacology; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D013329:Structure-Activity Relationship; D013565:Sympatholytics / Q000037:antagonists & inhibitors; D013566:Sympathomimetics / Q000037:antagonists & inhibitors; D014403:Tubocurarine / Q000494:pharmacology
D004220:Disulfides; D006584:Hexamethonium Compounds; D009150:Mustard Compounds; D009284:Naphthols; D009578:Nitrobenzenes; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D013565:Sympatholytics; D013566:Sympathomimetics; D009388:Neostigmine; D002110:Caffeine; D009538:Nicotine; D004491:Edrophonium; D002217:Carbachol; D000109:Acetylcholine; D011188:Potassium; D004229:Dithiothreitol; D014403:Tubocurarine